Mak Mp
0000-0001-5876-6533
1 paper found
Refreshing results…
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651
Missing publications? Search for publications with a matching author name.